Novavax submits variations to expand approval in Australia and New Zealand for adolescents
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
The production suspension impacts commercial and clinical trial supply
Upon closing, the Quakertown business will become an independent company called Microsize
He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Conceptualized, designed, and manufactured in India for the world, Cios Fit is a mobile C-arm designed for demanding multidisciplinary environments in busy operating rooms
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
Subscribe To Our Newsletter & Stay Updated